PUBLICATION
The fish embryo test (FET): origin, applications, and future
- Authors
- Braunbeck, T., Kais, B., Lammer, E., Otte, J., Schneider, K., Stengel, D., Strecker, R.
- ID
- ZDB-PUB-141115-5
- Date
- 2015
- Source
- Environmental science and pollution research international 22(21): 16247-61 (Review)
- Registered Authors
- Braunbeck, Thomas, Otte, Jens
- Keywords
- Fish embryo test, FET, Validation, Alternative test method, OECD guideline, Acute toxicity, Tertogenicity, Genotoxicity, Endocrine disruption, Neurotoxicity, Biotransformation, Cytochrome P450
- MeSH Terms
-
- Animals
- Chorion/metabolism
- Embryo, Nonmammalian/drug effects
- Embryo, Nonmammalian/metabolism
- Endocrine Disruptors/metabolism
- Endocrine Disruptors/toxicity*
- Environmental Pollutants/metabolism
- Environmental Pollutants/toxicity*
- History, 20th Century
- Humans
- Inactivation, Metabolic
- Lethal Dose 50
- Toxicity Tests, Acute/history*
- Zebrafish
- PubMed
- 25395325 Full text @ Environ. Sci. Pollut. Res. Int.
Citation
Braunbeck, T., Kais, B., Lammer, E., Otte, J., Schneider, K., Stengel, D., Strecker, R. (2015) The fish embryo test (FET): origin, applications, and future. Environmental science and pollution research international. 22(21):16247-61.
Abstract
Originally designed as an alternative for the acute fish toxicity test according to, e.g., OECD TG 203, the fish embryo test (FET) with the zebrafish (Danio rerio) has been optimized, standardized, and validated during an OECD validation study and adopted as OECD TG 236 as a test to assess toxicity of embryonic forms of fish. Given its excellent correlation with the acute fish toxicity test and the fact that non-feeding developmental stages of fish are not categorized as protected stages according to the new European Directive 2010/63/EU on the protection of animals used for scientific purposes, the FET is ready for use not only for range-finding but also as a true alternative for the acute fish toxicity test, as required for a multitude of national and international regulations. If-for ethical reasons-not accepted as a full alternative, the FET represents at least a refinement in the sense of the 3Rs principle. Objections to the use of the FET have mainly been based on the putative lack of biotransformation capacity and the assumption that highly lipophilic and/or high molecular weight substances might not have access to the embryo due to the protective role of the chorion. With respect to bioactivation, the only substance identified so far as not being activated in the zebrafish embryo is allyl alcohol; all other biotransformation processes that have been studied in more detail so far were found to be present, albeit, in some cases, at lower levels than in adult fish. With respect to larger molecules, the extension of the test duration to 96 h (i.e., beyond hatch) has-at least for the substances tested so far-compensated for the reduced access to the embryo; however, more research is necessary to fully explore the applicability of the FET to substances with a molecular weight >3 kDa as well as substances with a neurotoxic mode of action. An extension of the endpoints to also cover sublethal endpoints makes the FET a powerful tool for the detection of teratogenicity, dioxin-like activity, genotoxicity and mutagenicity, neurotoxicity, as well as various forms of endocrine disruption.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping